MarketCap
Facebook
X
Telegram
Altimmune ROA | ALT
ROA Jährlich Altimmune
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.47 | -68.24 | -41.99 | -40.94 | -44.36 | -20.01 | -37.96 | -71.54 | -73.66 | 86.26 | -17.32 | -45.3 | -68.37 | -21.64 | -16.65 | -128.13 | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 86.26 | -128.13 | -40.08 |
ROA Vierteljährlich Altimmune
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34.05 | -39.51 | -32.79 | -48.24 | -53.75 | -54.52 | -42.07 | -50.84 | -46.12 | -31.9 | -31.9 | -42.34 | -39.51 | -40.2 | -29.47 | -43.61 | -42.82 | -38.87 | -29.42 | -36.67 | -29.37 | -21.3 | -15.68 | -35.91 | -34.93 | -31.97 | -30.38 | -34.68 | -31.13 | -30.66 | -26.78 | -74.23 | -74.87 | -65.44 | -59.65 | 142.96 | 177.92 | 178.64 | 185.36 | -23.48 | -17.66 | -25.24 | -17.32 | -23.05 | -37.44 | -27.65 | -45.3 | -59.15 | -61.11 | -66.33 | -68.37 | -48.14 | -26.06 | -22.17 | -21.64 | -12.77 | -11.97 | -19.34 | -16.65 | -0.15 | -10.69 | -9.1 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 185.36 | -74.87 | -22.44 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Eloxx Pharmaceuticals
ELOX
|
-44.15 | - | -5.68 % | $ 8.28 M |  USA |
 |
Enochian Biosciences
ENOB
|
-35.83 | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
-4.87 | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
1.93 | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
-87.54 | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
153.4 | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
48.24 | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
-2.85 | - | - | $ 4.47 B | USA |
 |
Frequency Therapeutics
FREQ
|
-103.31 | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
-80.54 | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
0.06 | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
-217.5 | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
-34.54 | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
37.42 | $ 9.97 | -2.25 % | $ 1.62 B | USA |
 |
Hepion Pharmaceuticals
HEPA
|
-269.64 | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
-164.0 | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
-21.78 | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-32.65 | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
29.23 | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
-73.11 | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
-47.74 | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-30.58 | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
-6981.52 | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-116.63 | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
-0.19 | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
86.37 | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
-286.61 | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
-85.0 | $ 9.17 | 5.04 % | $ 636 M | USA |
|
BiomX
PHGE
|
-625.96 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-70.04 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-137.13 | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
-95.75 | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-54.24 | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-4.6 | - | -6.08 % | $ 184 M | China |
 |
Cassava Sciences
SAVA
|
-76.86 | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
-43.96 | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
-205.76 | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-113.22 | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-92.07 | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-107.57 | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-62.08 | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-6.51 | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-37.99 | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-137.96 | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
2.88 | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
11.63 | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-47.98 | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
-198.56 | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-6.41 | - | - | $ 26.8 M | USA |